Chronic myelogenous leukemia (CML) presents a unique opportunity to develop therapeutic strategies using vaccination against a truly tumor-specific antigen that is also the oncogenic protein required for neoplasia. We have shown in phase I and II trials that a tumor-specific, bcr-abl-derived peptide vaccine can be safely administered to patients with ...
Javier, Pinilla-Ibarz +4 more
openaire +1 more source
Flow cytometric detection of BCR-ABL fusion proteins in leukemia patients via an immunobead assay
Peer ...
Weerkamp, F. +2 more
openaire +1 more source
Fusion oncoproteins orchestrate tumorigenesis and sustain malignant progression via a positive feedback mechanism. [PDF]
Ying W +7 more
europepmc +1 more source
Identification of a <i>Musashi2</i> translocation as a novel oncogene in myeloid leukemia. [PDF]
Spinler K +6 more
europepmc +1 more source
The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype [editorial; comment] [PDF]
openaire +1 more source
Olverembatinib for 8p11 myeloproliferative syndrome with a positive BCR-FGFR1 fusion gene: a case report. [PDF]
Wu M +6 more
europepmc +1 more source
Exosome and BCR-ABL mediated molecular alterations in endothelial cells in chronic myeloid leukemia: identification of seven genes and their regulatory network. [PDF]
Shen Z +16 more
europepmc +1 more source
Caffeic acid phenethyl ester induced apoptosis in chronic myeloid leukemia cells by inhibiting mitochondrial complex I. [PDF]
Li M +9 more
europepmc +1 more source
A case report of mixed-phenotype acute leukemia with atypical BCR::ABL1 e13a3 fusion gene. [PDF]
Zhou Y +8 more
europepmc +1 more source
Molecular genetic characteristics and clinical significance of childhood acute lymphoblastic leukemia. [PDF]
Zhu Z, Yan J.
europepmc +1 more source

